TheEdgeResearch
Home / Stocks / RBOT

Vicarious Surgical Inc. (RBOT)

OTC Healthcare Medical - Devices
$0.06 ▼ -0.55%
Market Cap
$418,697
Sector
Healthcare
Industry
Medical - Devices
Beta
1.92
52-Wk Range
0.0638-9.74
CEO
Stephen From
Country
US
Currency
USD

Vicarious Surgical Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Waltham, MA, US. The stock last traded at $0.06, down 0.55% on the session, giving a market capitalisation of $418,697. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of 0.0%. Its beta of 1.92 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.00
Price / Book
0.12
EV / EBITDA
-0.15
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
2.02
Current ratio
1.54
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
48
IPO date
2020-09-04
Headquarters
Waltham, MA, US
About Vicarious Surgical Inc.

Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics. Their innovative technology is designed to give surgeons a virtual, immersive presence within the patient's body, facilitating highly precise and minimally invasive operations. The company's primary product, the Vicarious System, is a sophisticated single-incision robot engineered specifically for procedures like ventral hernia repair. Established in 2014, Vicarious Surgical Inc. operates from its corporate headquarters in Waltham, Massachusetts.

Comparable companies

Vicarious Surgical Inc. is most often compared with the following Healthcare names:

BOLDHYPDINTSITRMMODDMYONXLPIIIPSTVQTTB
More research on RBOT
RBOT technical analysis RBOT TheEdge Score Compare against peers
Open full interactive analysis & DCF →